NAS10027,087+1.72%S&P7,401+0.65%GOLD$4,073−1.00%BTC$75,828−0.15%VIX24.55−12.88%latest tape · as of 20:03 UTC
The Screen · Industrials · Specialty Industrial Machinery
Dover Corporation
DOV · a US exchange · USD · Market cap $27.6B · 24,000 employees
Dover Corporation provides equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services worldwide.
Positioning political buying, disclosed 2026-09-11
Options put/call open interest 0.43, read 2026-11-05
Ethical passes the values gate
Price202.56 USD
Fair value240.32
Ethical score82.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-11Read Accumulation191.48+5.8% to today ✓Markdown gives way to Accumulation after an 11% slide in 14 weeks
2026-07-02Read Markdown214.76-5.7% to today ✓First review on file: Markdown with results news in the headlines
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Dover Corporation holds its Accumulation at $202.56. The statistical read favours the buyers, held for 13 days.
As held on the ledger · 2026-11-05
Phase
Accumulation
Quantitative state
The statistical read favours the buyers, held for 13 days
Price at the screen
$202.56
Valuation
24.24 trailing · 17.63 forward price to earnings
Values screen
PASS· score 82.0
Beta
1.13
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
26.63%
Below 33%
Interest-bearing debt is just 26.6% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
22.71%
Below 49%
Money owed to the company is 22.7% of assets, under the 49% limit.
Pass
Revenue purity
0.90%
Below 5%
Only 0.9% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Dover clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 27%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when DOV's ethical verdict changes
Today DOV passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 12% discount to our $240.32 fair value, moderate competitive moat, 7.50% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 15.7% discount to the base estimate.
Where our models see it going: fair-value estimate $240.32, with a range of $176.72 to $294.54, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Solid Machinery Maker Priced Past Its Value
Dover builds the pumps, valves and presses that factories rely on day after day. The kit works, margins sit at 13 percent and revenue is rising 10 percent a year. Yet the shares trade at 18.5 times forward earnings while our fair value sits well below the current 214 dollar price.
We pass for one simple reason. The market already prices in more growth than the numbers support and the moderate moat offers little protection if orders slow. Eighteen analysts still say buy with a 255 dollar median target, but that optimism ignores how quickly industrial spending can turn.
Return on equity at 15 percent is respectable yet nothing special in this sector. Currency swings and any dip in capital spending would hit results fast. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
DOV trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Accumulation$212.66+2.2%Entry 17
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (21 analysts) rates it buy, with a mean price target of $249.
2026-10-29Accumulation$207.99+6.2%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.2% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (21 analysts) rates it buy, with a mean price target of $249.
2026-10-22Accumulation$195.80+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (21 analysts) rates it buy, with a mean price target of $249. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Accumulation$195.80+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (21 analysts) rates it buy, with a mean price target of $249. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Accumulation$195.80+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (21 analysts) rates it buy, with a mean price target of $249. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Accumulation$195.80+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (21 analysts) rates it buy, with a mean price target of $249. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Accumulation$195.80+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (21 analysts) rates it buy, with a mean price target of $249. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17Accumulation$195.80+0.9%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (21 analysts) rates it buy, with a mean price target of $249. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Accumulation$194.09+2.8%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.8% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (21 analysts) rates it buy, with a mean price target of $249. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15Accumulation$188.83-1.4%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.4% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 10% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (21 analysts) rates it buy, with a mean price target of $249. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
